Abbott India Ltd SHARE PRICE [LIVE]

  
NSE: ABBOTINDIA
21,278.25
BSE: 500488
21,182.45
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
34.75%
Sector
-10.34%
Sensex
4.86%
Outperformed both Sector by 45.09% and Sensex by 29.89%
IndustryPharma
MARKET CAP (Large Cap Stock)Rs 44,559 Cr
PE (TTM) 50.53
DIVIDEND YIELD 1.31%
PE Ratio50.53
Price to Book Value16.41
EV to EBIT38.73
EV to EBITDA36.46
EV to Capital Employed40.43
EV to Sales8.31
PEG Ratio2.21
Dividend Yield1.31%
ROCE (Latest)104.40%
ROE (Latest)32.48%
NameDec 22Sep 22
Promoters (Change:0.00) 74.99%74.99%
FIIs (Change:-0.00) 0.2%0.2%
Mutual Funds (Change:0.74) 6.41%5.67%
Insurance Companies (Change:-0.20) 1.84%2.04%
Other DIIs (Change:-0.01) 0.14%0.15%
Non Institution (Change:-0.53) 16.42%16.95%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Abbott India Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

ABBOTINDIA News

Frequently Asked Questions

What is the Share price of ABBOTT INDIA LTD. (ABBOTINDIA)?

ABBOTT INDIA LTD. (ABBOTINDIA) share price as of February 8, 2023, on NSE is Rs 21,278.25 (NSE) and Rs 21,182.45 (BSE) on BSE.

Can I buy ABBOTT INDIA LTD. (ABBOTINDIA) shares?

Yes, You can buy ABBOTT INDIA LTD. (ABBOTINDIA) shares by opening a Demat account with Angel One.

How do I buy ABBOTT INDIA LTD. (ABBOTINDIA) from Angel One?

ABBOTT INDIA LTD. (ABBOTINDIA) share can be brought through the following modes:
  1. Direct investment: You can buy ABBOTT INDIA LTD. (ABBOTINDIA) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to ABBOTT INDIA LTD. (ABBOTINDIA) shares.

In which sector do ABBOTT INDIA LTD. (ABBOTINDIA) belong?

ABBOTT INDIA LTD. (ABBOTINDIA) belongs to Pharma.

Is Abbott India a Debt free Company?

Yes, Abbott India is a debt free company.

What is the main business of Abbott India?

The main business of Abbott India is to offer high-quality medicines in therapeutic categories, including women’s health, cardiology, primary care, gastroenterology, and metabolic disorders.

Who are the promoters of Abbott India?

The primary promoters of Abbott India are Abbott Capital India Limited, Abbott Healthcare Products Limited, and British Colloids Limited.

What are the peers of Abbott India?

The top 5 peers of Abbott India are GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Ltd, Sanofi India Ltd, AstraZeneca Pharma India Ltd. and Procter & Gamble Health Ltd.

About ABBOTINDIA

Today's live share price for Abbott India Ltd is NSE: ₹ 21,278.25, BSE: ₹ 21,182.45 with a current market capitalization of .

Abbott India Ltd is one of the largest MNC pharma company operating in India. The Company is engaged in the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. They are having their presence in both OTC drugs and formulations. Their manufacturing facilities are located at Verna in Goa. The company's global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions. The Primary Care division markets products in the areas of pain management and gastroenterology. The Specialty Care-Methabolics and Urology division provides solutions in the areas of thyroid, obesity, diabetes and benign prostatic hyperplasia. The Specialty Care-Neuroscience division has a varied portfolio with specialty products in neurology and psychiatric segments. Hospital Care offers products in the field of anesthesiology and neonatology, such as Forane, Sevorane and Survanta. Abbott India Ltd was originally incorporated on August 22, 1944 as Boots Pure Drug Company (India) Ltd. The company name was changed to The Boots Company (India) Ltd on November 1, 1971, thereafter to Boots Pharmaceuticals Ltd on January 1, 1991. In October 31, 1995 the name was changed to Knoll Pharmaceuticals Ltd, and in July 1, 2002, they got their present name Abbott India Ltd. In the year 2002, the company sold their Jejuri Undertakings together with assets and liabilities as a going concern. In the year 2003, the company's wholly owned subsidiary company, Lenbrook Pharmaceuticals Ltd was amalgamated with the company. In the year 2004, the company started the production of Capsules with the capacity of 27 Millions Nos. In the year 2005, they further increased the capacity to 56 Million Nos. Also, they started a new project of producing Nutritional Products with the installed capacity of 600 Tonnes. In the year 2006, the company increased the production capacity of Tablets by 236 Million Nos to 686 Million Nos. In the year 2008, they further increased the production capacity of Tablets by 769 million Nos to 1455 million Nos. They launched Digene Total, buffered pantoprazole tablet for quick and sustained antacid action and Brugel a novel formulation for sprains and strains. Also, they launched Thyronorm 150, Digene Sugar Free Tablet and Gel during the year. The company acquired Solvay Pharmaceuticals, pursuant to which Solvay became a part of Abbott's global Pharmaceutical Products Group.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers